A Study of HFB301001 in Adult Patients With Advanced Solid Tumors
This research is testing a new medication, HFB301001, in adults who have cancer that has spread in their body. It's a very early study, meaning it's the first time this specific treatment is being given to people. The main goal is to understand how the medicine behaves in the human body, what dose is safe, and what side effects it might have. This information is crucial for deciding if the treatment can be studied further in larger groups of people. This type of early study helps doctors learn more about new ways to fight different types of advanced cancer.
At a glance
What is this study about?
This clinical trial is like a first step in testing a brand new medicine, called HFB301001, for people who have advanced cancer. When we say 'advanced cancer,' it means the cancer has spread from where it started to other parts of the body. Doctors are always looking for new and better ways to treat cancer, and studies like this are how those new treatments are discovered and developed.
In this very early phase, the main focus is on safety. The researchers want to carefully watch how people react to HFB301001. They will be looking at things like what dose is safe to give, how the medicine moves through and out of the body, and what side effects might occur. It's not about seeing if the medicine cures cancer at this stage, but more about understanding its basic effects in humans.
Because it's a new treatment, there's a lot to learn, and participating in such a study contributes hugely to medical knowledge. The information gathered from this study will be used to decide if HFB301001 should be tested in more people and in further stages of research, getting us closer to potentially new treatment options for cancer patients in the future.
Key takeaways
- It's a very early-stage study (Phase I) for a new cancer treatment.
- The new treatment is called HFB301001.
- It's for adults (18+) with advanced cancer that has spread.
- The main aim is to check the treatment's safety and how it acts in the body.
- Taking part means regular hospital visits for checks and tests.
- You can leave the study at any time if you change your mind.
Who may be eligible?
To be considered for this study, you must be an adult aged 18 years or older. There is no upper age limit, meaning people of all adult ages are welcome to be considered.
This study is for people who have been diagnosed with advanced cancer. This means your cancer has spread beyond its original spot. Both men and women are able to take part if they meet all the other requirements.
There will be other, more detailed reasons why someone might or might not be able to join the study. These could be related to your general health, other medical conditions you might have, or previous cancer treatments you've received. A study doctor will discuss all these with you carefully.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Have you been diagnosed with advanced cancer (cancer that has spread)?
- Are you willing to attend regular hospital appointments?
- Are you able to understand and sign a consent form?
What does participation involve?
If you decide to take part in this study, you would first have a thorough medical check-up to make sure it's safe for you. You would receive the study medication, HFB301001, according to a specific schedule decided by the research team. This medicine might be given in different ways, like by mouth or injection, and the doctors will explain this to you.
You would need to attend regular appointments at the hospital or clinic. During these visits, doctors and nurses would monitor your health carefully. This would involve a range of assessments, such as blood tests, physical examinations, and possibly scans, to see how your body is reacting to the treatment and to check for any side effects. These visits might be frequent at the beginning and then become less often over time.
The total length of time you would be in the study can vary. After you stop taking the study medication, you would likely have some follow-up appointments to check on your long-term health. The study team will explain the full schedule and duration to you before you agree to take part.
Potential risks and benefits
Locations (1)
- —UnverifiedSpain
Common questions
What does 'advanced solid tumors' mean?
It refers to cancer that has grown from a solid mass and has spread from where it started to other parts of the body.
What does 'Phase I' mean for a clinical trial?
Phase I means it's the very first time this new treatment is being given to people. The main focus is on checking its safety and finding the right dose.
Will this study cure my cancer?
At this early stage, the study's main goal is to understand how the new medicine works and if it's safe, not to cure cancer. Any effects on cancer are a secondary measurement.
Will I have to pay to join this study?
No, you will not have to pay for the study treatment or for your participation in the trial. All study-related costs are covered by the research sponsor.
Can my own doctor still look after me?
Yes, your regular doctors will continue to look after your general health. The study team will work with your usual medical team, and you'll still see your own GP and specialists as needed.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.